维普期刊资源整合服务平台（V6.5）

428篇 您的检索式：作者名="GERTZ MA"

选中清除导出查看参考文献查看引证文献引用追踪共22页首页上一页第1页下一页末页 /22 跳转

	题名	作者	年代	出处	被引量
1	Prediction of survival using absolute lymphocyte count for newly diagnosed patients with multiple myeloma: a retrospective study 显示文摘	EGE H GERTZ MA MARKOVIC SN	2008	Br J Haematol2008，141，6：	1
2	Pomalidomide (CC40M7) plus low-dose dexamethasone as therapy for relapsed multiple myeloma显示文摘	Lacy MQ Hayman SR Gertz MA		0，，：	1
3	Review of 1027 Patients With Newly Diagnosed Multiple Myeloma显示文摘	Kyle RA Gertz MA Witzig TE		0，，：	1
4	Update on treatment recommendations from the Fourth International Wor- kshop on Waldenstrom's Macroglobulinemia 显示文摘	Dimopoulos MA Gertz MA Kastritis E	2009	J Clin Oncol2009，27，1：	1
5	Primary systemic amyloidosis: clinical and laboratory features in 474 cases显示文摘	Kyle RA Gertz MA	1995	Semin Hematol1995，32，1：	1
6	Splenectomy for immune thrombocytopenic purpura: Long term results and treatment of postsplenectomy relapses 显示文摘	Kumar S Diehn FE Gertz MA	2009	Ann Hematol2009，81，2：	1
7	Current status of stem cell mobilization显示文摘	Gertz MA	2010	Br J Haematol2010，150，6：	1
8	Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)显示文摘	Lacy MQ Hayman SR Gertz MA		0，，：	1
9	Primary systemic amyloidosis with delayed progression to multiple myeloma显示文摘	Rajkumar SV Gertz MA Kyle RA	1998	Cancer1998，82，8：	1
10	New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes 显示文摘	Palladini G Dispenzieri A Gertz MA	2012	J Clin Oncol2012，30，36：	1
11	Primary systemic amyloidosis:clinical and laboratory features in 474 cases显示文摘	Kyle RA Gertz MA	1995	Semin Hematol1995，32，1：	1
12	Clinical value of minor responses after 4 doses of rituximab in Waldenstrom mac- roglobulinemia: a follow-up of the Eastern CooperatiVe Onco- logy Group E3A98 trial 显示文摘	Gertz MA Abonour R Heffner LT	2009	Br J Haematol2009，147，5：	1
13	Long-term survival in Waldenstrom macroglobulinemia:10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003显示文摘	Dhodapkar MV Hoering A Gertz MA		0，，04：	1
14	Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis(AL):a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis显示文摘	Gertz MA Comenzo R Falk RH	2005	Am J Hematol2005，79，：	1
15	Recent improvements in surviv- al in primary systemic amyloidosis and the importance of an early mor- tality risk score显示文摘	Kumar SK Gertz MA Lacy MQ	2011	Mayo Clin Proc2011，86，1：	1
16	Inhibitor of the thrombin time in systemic amyloidosis:a common coagulation abnormality显示文摘	Gastineau DA Gertz MA Daniels TM	1991	Blood1991，77，12：	1
17	IL-1beta expression in IgM monoclonal gammopathy and its relationship to multiple myeloma显示文摘	Dovovan KA Lacy MQ Gertz MA	2002	Leukemia2002，16，3：	1
18	Clinical impact and resource utilization after stem cell mobilization failure in patients with multiple myeloma and lymphoma 显示文摘	Gertz MA Wolf RC Micallef IN	2010	Bone Marrow Transplant2010，45，9：	1
19	Splerectomy for immuune thmmbocytopenic purpura:Iong-term results and treatmgat for postsphcnectomy relapses显示文摘	Kumar S Diehn FE Gertz MA	2002	Ann Hceatol2002，81，：	1
20	Combination therapy with thalidomide plus dexamthasone for newly diagnosed myeloma显示文摘	Rajkumar SV Hayman S Gertz MA	2002	J Clin Oncol2002，20，21：	1

返回顶部每页显示：

共22页首页上一页第1页下一页末页 /22 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示